Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
Retrospective cases series is a non-randomized, open-label, single-center investigation
(Retina Clinic, São Paulo, Brazil) of patients diagnosed with macular edema secondary to
diabetic retinopathy (DME) and retinal vein occlusions who underwent to simultaneous
treatment with intravitreal injection of bevacizumab 1.25mg and implant of dexamethasone
0.7mg.